Author:
Pikija Slaven,Peycheva Marieta V.,Aghayan-Ugurluoglu Rousan,Ganser Bernhard,Trinka Eugen
Abstract
Central retinal artery occlusion is a rare ophthalmological complication of sickle cell disease, usually provoked by additional contributing risk factors and its treatment remains controversial. We describe a patient with sickle cell disease and a spontaneous central retinal artery occlusion of his left eye that probably has good result from intravenous thrombolysis. We want to add sickle cell disease as rare etiological cause of central retinal artery occlusion and perpetuate evidence of intravenous recombinant tissue plasminogen activator administration in this condition.
Reference12 articles.
1. 1. Eaton WA. Hemoglobin S polymerization and sickle cell disease: A retrospective on the occasion of the 70th anniversary of Pauling’s Science paper. Am J Hematol 2020; 95(2):205–11.
2. 2. Bender MA. Sickle Cell Disease. 2003 Sep 15 [updated 2017 Aug 17]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021.
3. 3. Tsai JC, Denniston A, Murray P, et al. Hemoglobinopathies in Oxford American Handbook of Ophthalmology. Oxford University Press 2011:450–1.
4. 4. Fine LC, Petrovic V, Irvine AR, et al. Spontaneous central retinal artery occlusion in hemoglobin sickle cell disease. Am J Ophthalmol 2000; 129(5):680–1.
5. 5. Sorr EM, Goldberg RE. Traumatic central retinal artery occlusion with sickle cell trait. Am J Ophthalmol 1975; 80:648–52.